Funding opportunities

GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE

Funding Type: 
Disease Team Research I
Grant Number: 
DR1-06893
Principle Investigator: 
Institution: 
Funds requested: 
$8 278 722
Funding Recommendations: 
Recommended
Grant approved: 
Yes
Public Abstract: 
Statement of Benefit to California: 
Review Summary: 
Conflicts: 
  • John Rasko
  • John Wagner
  • Rainer Storb

© 2013 California Institute for Regenerative Medicine